Breast screening: using MRI with higher risk women
Technical guidelines for healthcare professionals screening women at a higher risk of developing breast cancer.
Applies to England
Documents
Details
Healthcare professionals working in NHS breast screening programme should use these guidelines.
They apply to the use of magnetic resonance imaging (MRI) equipment when screening higher risk women and include:
- standards for equipment and image acquisition
- reporting MRI examinations
- quality control and quality assurance
This publication was previously published by Public Health England, which closed on 30 September 2021.
Updates to this page
Last updated 27 September 2024 + show all updates
-
Added clarification that publication was previously published by Public Health England.
-
The Information has been updated and reformatted into HTML. This guidance has been revised specifically in the following areas: • there are more details on the image acquisition parameters in the new guidance in section 2.5. • there are more details on the viewing tools such as colour parametric software in section 2.6. • all women should have second-look ultrasound at assessment rather than a selected group (section 3.4) • short term recall should be undertaken between 3 and 6 months instead of between 6 and 12 months (section 3.6). • the updated report gives more details on undertaking QC using breast coil element check and Suppression effectiveness (section 4.1) • there are changes to the equipment standards stated in Appendix 2 • standards set out in Appendix 2 of 2012 report on standards for readers and centres have been removed. • the MRI accreditation form has been removed from the updated report.
-
First published.